EUVIMEDEUVIMED entdecken
Open Access

Patency outcomes of primary inferior vena cava repair in radical nephrectomy and tumor thrombectomy

Harshit Garg, Philip Whalen, Haneen Marji, Robert Cooper, Furkan Dursun, Mukund Bhandari, Lokesh Khanna, Lalithapriya Jayakumar, Michael A Liss, Robert S Svatek, Ronald Rodriguez, Dharam Kaushik und 1 weitere

Journal of Vascular Surgery: Venous and Lymphatic Disorders · 2023-05 · 11 (3) · 595-604.e2

DOI: 10.1016/j.jvsv.2023.01.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Vascular Surgery: Venous and Lymphatic Disorders, 2023-05. Verfasst von Harshit Garg und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University of Texas Health, San Antonio, TX. Hauptthemen laut MEDLINE: Kidney Neoplasms, Carcinoma, Renal Cell, Thrombosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: The reconstruction of inferior vena cava (IVC) during radical nephrectomy and venous tumor thrombectomy (RN-VTT) is mostly performed with primary repair or with a patch/graft. We sought to systematically evaluate the outcomes of IVC patency over short- to intermediate-term follow-up for patients undergoing primary repair of IVC and to assess the association with survival. METHODS: A retrospective review of patients undergoing RN-VTT between January 2013 and August 2018 was conducted. Patients were followed until death, last available follow-up, or March 2022. The patency outcomes and IVC diameters were studied using follow-up cross-sectional imaging. The χ2 test, Student t test, and Kaplan-Meier survival analysis were used. RESULTS: Seventy-seven patients were included. The mean age was 59.2 ± 12.2 years and 45.4% had Mayo classification level III thrombus or higher. At a median follow-up of 36.5 months (13.3-60.7 months), the 3-year overall survival (OS) was 64%. Sixty patients underwent primary repair of the IVC and 48 of these patients were assessed for IVC patency. Ten patients (20.8%) developed caval occlusion, either from recurrent tumor (8.3%), new-onset bland thrombus (8.3%), or stenosis (4.2). The IVC patency seemed to be a significant predictor of OS (hazard ratio, 2.85; P = .021). Although the IVC diameters decreased significantly at the 3-month postoperative scan at the infrarenal (P = .019), renal (P < .001), and suprarenal (P < .001) levels, they did not decrease further on long-term follow-up imaging. CONCLUSIONS: IVC reconstruction with primary repair results in an overall patency rate of 80.2% with only a 4.0% rate of stenosis. Recurrence of tumor thrombus (8.3%) or bland thrombus (8.3%) are the predominant reasons for IVC occlusion after RN-VTT, and this outcome is associated with poor OS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney NeoplasmsCarcinoma, Renal CellThrombosisHumansMiddle AgedAgedVena Cava, InferiorConstriction, PathologicNeoplasm Recurrence, LocalThrombectomyRetrospective StudiesNephrectomy

Stichwörter der Autor:innen

IVC occlusionIVC patencyInferior vena cava repairRadical nephrectomyVenous tumor thrombectomy

Autor:innen und Institutionen

  • Department of Urology, University of Texas Health, San Antonio, TX.
  • University of the Incarnate Word School of Osteopathic Medicine, San Antonio, TX.
  • Department of Radiodiagnosis, University of Texas Health, San Antonio, TX.
  • Department of Population Health Science, University of Texas Health, San Antonio, TX.
  • Vascular Health Partners of Community Care Physicians, PC, Latham, NY.
  • Department of Urology, University of Texas Health, San Antonio, TX. Electronic address: pruthi@uthscsa.edu.

Zitieren

APA

Garg, H., Whalen, P., Marji, H., Cooper, R., Dursun, F., Bhandari, M., Khanna, L., Jayakumar, L., Liss, M. A., Svatek, R. S., Rodriguez, R., Kaushik, D., & Pruthi, D. K. (2023). Patency outcomes of primary inferior vena cava repair in radical nephrectomy and tumor thrombectomy. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 11(3), 595-604.e2. https://doi.org/10.1016/j.jvsv.2023.01.004

Vancouver

Garg H, Whalen P, Marji H, Cooper R, Dursun F, Bhandari M, et al. Patency outcomes of primary inferior vena cava repair in radical nephrectomy and tumor thrombectomy. Journal of Vascular Surgery: Venous and Lymphatic Disorders. 2023;11(3):595-604.e2. doi:10.1016/j.jvsv.2023.01.004

BibTeX
@article{Garg2023,
  author = {Garg, Harshit and Whalen, Philip and Marji, Haneen and Cooper, Robert and Dursun, Furkan and Bhandari, Mukund and Khanna, Lokesh and Jayakumar, Lalithapriya and Liss, Michael A and Svatek, Robert S and Rodriguez, Ronald and Kaushik, Dharam and Pruthi, Deepak K},
  title = {Patency outcomes of primary inferior vena cava repair in radical nephrectomy and tumor thrombectomy},
  journal = {Journal of Vascular Surgery: Venous and Lymphatic Disorders},
  year = {2023},
  volume = {11},
  number = {3},
  pages = {595--604.e2},
  doi = {10.1016/j.jvsv.2023.01.004}
}
Kostenlos starten →